Rupatadine Fumarate Tablets
Belongs to Category:
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
Product Description
Approval Number:
H20243697
Indications:
For the symptomatic treatment of allergic rhinitis and urticaria in adults and adolescents (over 12 years old).
Administration:
Adults and Adolescents (over 12 years old): The recommended dose is 10 mg (one tablet), one tablet a day, which can be taken before or after meals.
Elderly People: Elderly people should use this product with caution.
Children: The safety and efficacy of this product in children under 12 years old have not been determined, so it is not recommended for use.
Patients with Impaired Renal or Hepatic Function: Clinical experience in treating patients with impaired renal or hepatic function has not been obtained, so it is not recommended for use.
Specifications:
10mg x 7 tablets, 10mg x 10 tablets
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
The main products cover cardiovascular diseases, diabetic complications, anti-tumor, calcium supplementation, digestive system, respiratory system, and orthopedics.
Related Products
Online Message
We will contact you within one business day. Please pay attention to your email.
Email: marcos.yuan@wangao.com.cn
Address: No. 688, Dinghai Road, Haimen City, Jiangsu Province
Mobile Version QR Code
WeChat Official Account
Copyright © 2025 Jiangsu Wangao Pharmaceutical Co., Ltd.